Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ALX Oncology Holdings Inc. (ALXO) vs Coherus Oncology, Inc. (CHRS)

ALX Oncology Holdings Inc. and Coherus Oncology, Inc. are both Biotechnology companies. ALX Oncology Holdings Inc. and Coherus Oncology, Inc. are of similar size ($187.4M and $183.9M). ALX Oncology Holdings Inc. has the higher net margin (0.00% vs −259.4%) and the lower return on invested capital (−673.3% vs 0.00%). Across the 17 metrics below, ALX Oncology Holdings Inc. leads on 10 and Coherus Oncology, Inc. on 7.

Valuation

Metric ALXO CHRS Biotechnology median
P/E n/m n/m 7.88
P/S 72.88 3.43 11.47
P/B 1.30 2.88 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 22.31 5.53 10.73
Earnings yield (86.26%) (91.15%) (28.84%)
Free cash flow yield (39.90%) (106.88%) (23.03%)

Profitability

Metric ALXO CHRS Biotechnology median
Gross margin 0.00% 68.94% 65.16%
Operating margin 0.00% (311.56%) 0.00%
Net margin 0.00% (259.41%) 0.00%
Free cash flow margin 0.00% (365.22%) 0.00%
Return on equity (80.65%) (146.27%) (57.72%)
Return on assets (63.16%) (41.90%) (49.22%)
Return on invested capital (673.30%) 0.00% 0.00%

Growth

Metric ALXO CHRS Biotechnology median
Revenue growth (TTM) — 61.00% 5.64%
EPS growth (last fiscal year) 26.36% 472.00% —
Revenue growth, 5-year CAGR — (38.41%) 8.40%
Net income growth, 5-year CAGR 0.00% 4.91% 0.00%

Health

Metric ALXO CHRS Biotechnology median
Debt to equity 0.07 0.61 0.00
Current ratio 9.71 1.77 4.73
Net debt to EBITDA 0.34 0.76 0.96

Dividend

Metric ALXO CHRS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ALXO CHRS Biotechnology median
Market cap 187.37m 183.86m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack